The Soviet Mikoyan MiG-23 “Flogger,” a variable-sweep wing fighter designed in the late 1960s to succeed the MiG-21, became ...

Aardvark Therapeutics, Inc. announced progress in its Phase 3 HERO trial for ARD-101, aimed at treating hyperphagia associated with Prader-Willi Syndrome, with data expected in early 2026. The ...

Archaeologists confronted by a false door at an excavation site were stunned to find that it led to the tomb of Egyptian royalty. The Egyptian Ministry of Tourism and Antiquities announced the ...

Khufu's is restaurant located near the Egyptian pyramids (Photo: Instagram/ khufusrestaurant) If Egypt is on your travel list, chances are the Pyramids of Giza are already marked as a must-see.

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for metabolic diseases, has announced its presentation schedule for May 2025 ...

The discovery sheds some light on a "lost" dynasty of pharaohs who ruled during a little-understood time in ancient Egypt's long history. Archaeologists from Egypt and the U.S. unearthed the tomb ...

The joint Egyptian-Chinese air force drill “Eagles of Civilization 2025” has commenced in Egypt, set to be conducted over several days at an Egyptian air base. Multi-role fighter aircraft of various ...

A new AI weather prediction system called Aardvark Weather delivers accurate forecasts faster with thousands of times less computing power than current AI and physics-based forecasting systems.

How can artificial intelligence (AI) help predict weather forecasts with better accuracy and efficiency than current weather forecast methods? This is what a recent study published in Nature hopes to ...

A new AI weather prediction system, Aardvark Weather, can deliver accurate forecasts tens of times faster and using thousands of times less computing power than current AI and physics-based ...

In this article, we are going to take a look at where Aardvark Therapeutics, Inc. (NASDAQ:AARD) stands against other stocks with at least $10 million in insider spending recently. Since Donald ...

Shares of obesity drug developer Aardvark Therapeutics (NASDAQ:AARD) closed 11% lower following the company's $94M initial public offering. Aardvark (NASDAQ:AARD) shares opened at $15.18 after ...